Stock-Based Compensation | 7. STOCK-BASED COMPENSATION The Company has two stock-based compensation methods available when determining employee compensation. (1) Long-Term Incentive Compensation Plans Long-Term Incentive Compensation Plan The Long-Term Incentive Compensation Plan provides for shares of common stock to be awarded to officers and key employees based on performance targets set by the Compensation Committee of the Board of Directors (the “Committee”). The Company’s shareholders previously approved 700,000 shares to be issued under the plan. As of September 30, 2019 , 102,183 shares have been issued. The Committee selected fully-diluted earnings per share and total shareholder return as the performance goal for the three -year performance periods July 1, 2017 – June 30, 2020 (2018-2020) and July 1, 2018 – June 30, 2021 (2019-2021) . For the July 1, 2019 – June 30, 2022 (2020-2022) three -year performance period, the Committee selected Adjusted Earnings Before Interest and Tax with a defined percentage growth in fiscal year 2021 and 2022 . Stock awards will be issued to participants as soon as practicable following the end of the performance periods subject to verification of results and C ommittee approval. The compensation cost related to the number of shares to be granted under each performance period is fixed on the grant date, which is the date the performance period begins. During the quarter ended September 30, 2019, the Company increased the provision in the amount of $0.1 million . During the quarter ended September 30, 2018, the Company recorded no plan expense. If the target performance goals for 2018-2020, 2019-2021 and 2020-2022 plans would be achieved, the total amount of compensation cost recognized over the requisite performance periods would be $ 0 . 8 million, $0.5 million and $0.3 million, respectively. (2) Stock Plans Omnibus Stock Plan The Omnibus Stock Plan is for key employees, officers and directors and provides for the granting of incentive and nonqualified stock options, restricted stock, restricted stock units, stock appreciation rights and performance units. The Company’s shareholders previously approved 700,000 shares to be issued under the plan. Under the Omnibus Stock Plan, options are granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years. It is the Company’s policy to issue new shares upon exercise of stock options. The Company accepts shares of the Company’s common stock as payment for the exercise price of options. Shares received as payment are retired upon receipt. During the quarter ended September 30, 2019, the Company issued options for 30,000 common shares to its Chief Executive Officer, in lieu of a cash bonus, which was expensed in the prior year. During the quarter ended September 30, 2018, the Company issued options for 36,095 common shares and recorded expense of $0.3 million related to stock option grants. Under the Omnibus Stock Plan, the Company issued 5,425 and 2,590 shares to non-executive directors as compensation and recorded expense of $0.1 million during the quarters ended September 30, 2019 and 2018, respectively . During the quarter ended September 30, 2019, the Company recorded $0.8 million in restructuring expense for grants of an aggregate 167,760 restricted stock units and 10,382 restricted stock shares under the plan to executives as per their notification of award letters dated July 1, 2019 . These restricted stock units and restricted stock shares were granted by the Compensation Committee to serve as a retention incentive for the executives during the restructuring. The restricted stock units vest over an 18 -month period. The Company also recorded $0.1 million compensation expense for grants of an aggregate 43,929 restricted stock units under the plan to executives as per their notification of award letters dated July 19, 2019. During the quarter ended September 30, 2019, the Company recorded $0.1 million compensation expense related to 30,000 restricted stock units, 30,000 options and 3,186 restricted stock shares which were awarded to its Chief Executive Officer as per a notification of award letter s dated December 28, 2018. During the quarter ended September 30, 2018, the Company recorded $0.2 million compensation expense for grants of an aggregate 39,666 restricted stock units under the plan to four executive officers as per their notification of award letters dated July 1, 2018. At September 30, 2019, 184,030 shares were available for future grants under the plan. 2006 and 2009 Stock Option Plans The 2006 and 2009 Stock Option Plans are for key employees, officers and directors and provide for granting incentive and nonqualified stock options. Under the plans, options were granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years. All options were exercisable when granted. No additional options can be granted under the 2006 and 2009 Stock Option Plans. (3) Outside a Plan During the quarter ended December 31, 2018, the Company awarded its Chief Executive Officer 55,000 options outside any Company stock plan. The Company recorded $20 thousand compensation expense related to this grant during the quarter ended September 30, 2019. (4) Summary A summary of the status of the Company’s stock option plans as of September 30, 2019 , June 30, 2019 and 2018 and the changes during the periods then ended is presented below: Weighted Shares Average (in thousands) Exercise Price Outstanding at June 30, 2018 166 $ 30.65 Granted 100 26.89 Exercised (5) 15.50 Cancelled (36) 36.59 Outstanding at June 30, 2019 225 $ 28.37 Granted 30 15.14 Cancelled (12) 32.99 Outstanding at September 30, 2019 243 $ 26.50 The following table summarizes information for options outstanding at September 30, 2019 : Options Weighted Average Range of Outstanding Remaining Exercise Prices (in thousands) Life (Years) Price $ 8.55 - 15.14 44 7.3 $ 14.11 17.23 - 19.77 23 2.4 18.81 20.50 - 27.57 93 7.2 24.16 31.06 - 32.80 49 7.0 32.27 43.09 - 47.45 34 7.0 45.34 $ 8.55 - 47.45 243 6.3 $ 26.50 |